Noopept (Omberacetam), (30mg/capsule), 60 Capsules
$24.99
Noopept (Omberacetam) is a synthetic dipeptide analog of the racetam family, known for its role in glutamatergic and cholinergic signaling pathways. It exhibits high affinity for AMPA and NMDA receptors, contributing to its involvement in synaptic transmission and neurochemical Research use only | Third-party lab tested.
Buy Noopept (Omberacetam), (30mg/capsule), 60 Capsules – Swiss Chems USA
Noopept (Omberacetam), (30mg/capsule), 60 Capsules — Research Overview
Noopept (Omberacetam) is a synthetic dipeptide analog of the racetam family, known for its role in glutamatergic and cholinergic signaling pathways. It exhibits high affinity for AMPA and NMDA receptors, contributing to its involvement in synaptic transmission and neurochemical interactions.
This compound undergoes rapid hydrolysis into bioactive peptide fragments, facilitating its metabolic activity. Noopept is processed through hepatic oxidation and conjugation, with primary clearance occurring via renal excretion.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
Intended use: This material is supplied for laboratory and in-vitro research only. It is not a drug, food, or cosmetic and is not intended for human or animal consumption.
Noopept (Omberacetam), (30mg/capsule), 60 Capsules Research Applications
Noopept (ethyl 1-(phenylacetyl)-L-prolylglycinate) is a synthetic dipeptide-derived small molecule and prodrug of cycloprolylglycine (cPG), an endogenous cyclic peptide. Following biotransformation, it yields cycloprolylglycine, a metabolite investigated for its interactions with glutamatergic signaling systems, including AMPA- and NMDA receptor-associated pathways. Experimental studies have also examined Noopept’s interactions with peptide-mediated regulatory mechanisms, receptor-associated signaling networks, and molecular communication pathways involved in signal transduction. Additional investigations have explored its effects on protein interaction systems, transcriptional regulation processes, and small molecule–peptide pharmacology. Research applications include AMPA/NMDA receptor pharmacology, glutamatergic signaling investigation, prodrug metabolism studies, cycloprolylglycine-related research, and mechanistic evaluation of receptor-associated regulatory systems. Supplied in 30 mg capsules. Independently third-party HPLC-tested; COA available per batch.
Noopept (Omberacetam), (30mg/capsule), 60 Capsules Frequently Asked Questions
What is cycloprolylglycine and why is Noopept considered its prodrug?
Cycloprolylglycine (cPG) is a cyclic dipeptide investigated in studies of peptide-mediated signaling systems and receptor-associated regulatory pathways. Noopept undergoes biotransformation to yield cPG as a principal metabolite, making it a useful research tool for examining prodrug conversion mechanisms, metabolite-associated pharmacology, and the relationship between parent compounds and biologically active peptide derivatives. This prodrug relationship distinguishes Noopept from compounds that act exclusively through direct receptor interactions.
How does Noopept differ from racetam-class compounds in pharmacology research?
Although frequently evaluated alongside racetam-class compounds, Noopept is structurally distinct as a dipeptide-derived molecule rather than a cyclic lactam. Experimental investigations have examined its interactions with glutamatergic signaling pathways, receptor-associated regulatory systems, and cycloprolylglycine-related mechanisms. These characteristics make Noopept a useful research tool for comparative studies involving small molecule–peptide pharmacology, prodrug metabolism, and receptor-mediated signaling processes.
What interactions between Noopept and protein aggregation systems have been investigated?
Experimental studies have examined Noopept in relation to protein aggregation pathways, molecular assembly processes, and protein-protein interaction systems. Investigations have explored its effects on aggregation dynamics, conformational stability, and structural organization within protein regulatory networks. These characteristics have contributed to its use in research involving molecular interaction pathways, protein assembly mechanisms, and structure-function relationship studies.
Research Use Disclaimer
All product information is provided for educational and laboratory research reference only. Any form of introduction into humans or animals is prohibited. Handle only in licensed research settings in accordance with applicable laws and institutional protocols.
| Weight | 3 lbs |
|---|

Reviews
There are no reviews yet.